Cargando…
Phage therapy in allergic disorders?
Allergic disorders pose a growing challenge to medicine and our society. Therefore, novel approaches to prevention and therapy are needed. Recent progress in studies on bacterial viruses (phages) has provided new data indicating that they have significant immunomodulating activities. We show how tho...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882018/ https://www.ncbi.nlm.nih.gov/pubmed/29359577 http://dx.doi.org/10.1177/1535370218755658 |
_version_ | 1783311396964925440 |
---|---|
author | Górski, Andrzej Jończyk-Matysiak, Ewa Łusiak-Szelachowska, Marzanna Międzybrodzki, Ryszard Weber-Dąbrowska, Beata Borysowski, Jan |
author_facet | Górski, Andrzej Jończyk-Matysiak, Ewa Łusiak-Szelachowska, Marzanna Międzybrodzki, Ryszard Weber-Dąbrowska, Beata Borysowski, Jan |
author_sort | Górski, Andrzej |
collection | PubMed |
description | Allergic disorders pose a growing challenge to medicine and our society. Therefore, novel approaches to prevention and therapy are needed. Recent progress in studies on bacterial viruses (phages) has provided new data indicating that they have significant immunomodulating activities. We show how those activities could be translated into beneficial effects in allergic disorders and present initial clinical data that support this hope. IMPACT STATEMENT: Allergic disorders pose a growing challenge to medicine and our society, so new approaches to prevention and therapy are urgently needed. Our article summarizes progress that has been recently made and presents a shift in our understanding of the immunobiological significance of bacterial viruses (phages). Currently, phages may be considered not only as mere “bacteria eaters” but also as regulators of immunity. The new understanding of phages as important factors in maintenance of immune homeostasis opens completely new perspectives for their use in controlling aberrant immune responses. It is likely that this new knowledge could be translated into novel means of immunotherapy of allergic disorders. |
format | Online Article Text |
id | pubmed-5882018 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-58820182019-03-01 Phage therapy in allergic disorders? Górski, Andrzej Jończyk-Matysiak, Ewa Łusiak-Szelachowska, Marzanna Międzybrodzki, Ryszard Weber-Dąbrowska, Beata Borysowski, Jan Exp Biol Med (Maywood) Immunology/Microbiology/Virology Allergic disorders pose a growing challenge to medicine and our society. Therefore, novel approaches to prevention and therapy are needed. Recent progress in studies on bacterial viruses (phages) has provided new data indicating that they have significant immunomodulating activities. We show how those activities could be translated into beneficial effects in allergic disorders and present initial clinical data that support this hope. IMPACT STATEMENT: Allergic disorders pose a growing challenge to medicine and our society, so new approaches to prevention and therapy are urgently needed. Our article summarizes progress that has been recently made and presents a shift in our understanding of the immunobiological significance of bacterial viruses (phages). Currently, phages may be considered not only as mere “bacteria eaters” but also as regulators of immunity. The new understanding of phages as important factors in maintenance of immune homeostasis opens completely new perspectives for their use in controlling aberrant immune responses. It is likely that this new knowledge could be translated into novel means of immunotherapy of allergic disorders. SAGE Publications 2018-01-23 2018-03 /pmc/articles/PMC5882018/ /pubmed/29359577 http://dx.doi.org/10.1177/1535370218755658 Text en © 2018 by the Society for Experimental Biology and Medicine http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Immunology/Microbiology/Virology Górski, Andrzej Jończyk-Matysiak, Ewa Łusiak-Szelachowska, Marzanna Międzybrodzki, Ryszard Weber-Dąbrowska, Beata Borysowski, Jan Phage therapy in allergic disorders? |
title | Phage therapy in allergic disorders? |
title_full | Phage therapy in allergic disorders? |
title_fullStr | Phage therapy in allergic disorders? |
title_full_unstemmed | Phage therapy in allergic disorders? |
title_short | Phage therapy in allergic disorders? |
title_sort | phage therapy in allergic disorders? |
topic | Immunology/Microbiology/Virology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882018/ https://www.ncbi.nlm.nih.gov/pubmed/29359577 http://dx.doi.org/10.1177/1535370218755658 |
work_keys_str_mv | AT gorskiandrzej phagetherapyinallergicdisorders AT jonczykmatysiakewa phagetherapyinallergicdisorders AT łusiakszelachowskamarzanna phagetherapyinallergicdisorders AT miedzybrodzkiryszard phagetherapyinallergicdisorders AT weberdabrowskabeata phagetherapyinallergicdisorders AT borysowskijan phagetherapyinallergicdisorders |